Search
Nervgen Pharma Ord Shs
NGENAdd to Watchlist
2.120USD
+0.030+1.44%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
171.78MMarket Cap
LossP/E TTM
Nervgen Pharma Ord Shs Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
239.63K
--
EPS(YoY)
-0.44
-79.23%
Analyst Rating
BUY
2026-07-02
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its current assets were 16.39M, with a year-on-year change of 21.48.
What are the total assets of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its total assets of Nervgen Pharma Ord Shs were 16.68M, with a year-on-year change of 20.66.
What are the total liabilities of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its total liabilities of Nervgen Pharma Ord Shs were 14.18M, with a year-on-year change of 18.21.
What is the total equity of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its total equity of Nervgen Pharma Ord Shs was 2.50M, with a year-on-year change of 36.70.
What is the net investment of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its net investment of Nervgen Pharma Ord Shs was 72.54K, with a year-on-year change of 73.66.
What is the net financing of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its net financing of Nervgen Pharma Ord Shs was 17.08M, with a year-on-year change of 6.07.
What is the Earnings Per Share (EPS) of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its Earnings Per Share (EPS) was -0.44, with a year-on-year change of -79.23.
What is the debt-to-asset ratio of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its debt-to-asset ratio was 0.04, with a year-on-year change of -93.35.
What is the Return on Equity (ROE) of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its Return on Equity (ROE) was -1457.57, with a year-on-year change of 82.77.
What is the Return on Assets (ROA) of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its Return on Assets (ROA) was -206.66, with a year-on-year change of -40.85.
What is the operating profit of Nervgen Pharma Ord Shs?
According to Nervgen Pharma Ord Shs's FY2025 earnings report, its operating profit was -18.02M, with a year-on-year change of -1.90.